Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-25-009898
Filing Date
2025-03-28
Accepted
2025-03-28 16:40:49
Documents
19
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A govx20250327_pre14a.htm   iXBRL PRE 14A 815181
6 capnet.jpg GRAPHIC 32454
7 captsr.jpg GRAPHIC 34444
8 reynoldssig.jpg GRAPHIC 2253
  Complete submission text file 0001437749-25-009898.txt   1574907

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA govx-20241231.xsd EX-101.SCH 4076
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20241231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20241231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20241231_pre.xml EX-101.PRE 714
21 EXTRACTED XBRL INSTANCE DOCUMENT govx20250327_pre14a_htm.xml XML 104324
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39563 | Film No.: 25787052
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)